Jiangsu Hengrui Medicine Company Ltd.

Shanghai Hengrui Pharmaceutical Co., Ltd.

Zhenxing Du

Qiyun Shao

Likun Wang

Feng He

Jun Feng

Jie Wang

Lin Wang

Chao Xu

Long Han

Yahui Ma

Weidong Lu

Haoyu Zhang

Lijuan Zhai

Junran Yang

Qi Wu

The present disclosure relates to a crystal form of a pyridopyrimidine derivative and a preparation method thereof, and specifically relates to the crystal form of the compound of formula (I) and a preparation method thereof. The new crystal form has good physical and chemical properties, thereby facilitating clinical treatments.

Crystal form of pyridopyrimidine derivative and preparation method thereof

Provided are a crystal form of an oxopicolinamide derivative and a preparation method therefor. In particular, provided are crystal forms A, B, C, D, E, and F of a compound as shown in formula (I) and a preparation method therefor. Crystal forms A, B, C, D, E, and F of the compound of formula (I) obtained in the present disclosure have good crystal stability and chemical stability, and can be better used in clinical treatment. 

Crystal form of oxopicolinamide derivative and preparation method therefor

The present invention relates to crystal forms of an oxypyridine amide derivative and a preparation method therefor. In particular, the present invention relates to crystal forms A, B, C, D, E and F of a compound represented by formula (I) and a preparation method therefor. The crystal forms of the compound represented by formula (I) as described in the present invention have good crystal form stability and may be better for clinical use.

Crystal forms of oxypyridine amide derivative and preparation method therefor

This application describes a crystal of a benzofuran derivative free base and a preparation method. Specifically, this application describes crystal A, crystal B, crystal C, and crystal D of N-((4,6-dimethyl-2-carbonyl-1,2-dihydropyridin-3-yl)methyl)-5-ethyl-6-(ethyl(tetrahydro-2H-pyran)4-yl)amino)-2-(piperidin-1-ylmethyl)benzofuran-4-carboxamide and a preparation method for the crystals. The crystals of the compound of formula (I) have great crystal stability and provides improved uses in clinical treatment. 

Crystal of benzofuran derivative free base and preparation method

A crystalline form of alkynyl pyridine prolyl hydroxylase inhibitor and a method for preparing same are described. Specifically, a new crystalline form of alkynyl pyridine prolyl hydroxylase inhibitor as represented by formula (I) is described. The new crystalline form of the present invention has good stability and may be better used for clinical treatment. 

Crystalline form of alkynyl pyridine prolyl hydroxylase inhibitor and method for preparing same

Growing community of inventors

Jiangsu, China

Zhenxing Du